Qube Research & Technologies (QRT)’s Moderna MRNA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$52.1M	Sell	1,024,900 -785,800	-43%	-$36.7M	0.06%	416
2025 Q4	$53.4M	Buy	1,810,700 +230,400	+15%	+$6.26M	0.05%	457
2025 Q3	$40.8M	Sell	1,580,300 -270,000	-15%	-$7.53M	0.04%	552
2025 Q2	$51M	Buy	1,850,300 +598,000	+48%	+$15.7M	0.05%	457
2025 Q1	$35.5M	Buy	1,252,300 +740,300	+145%	+$26.3M	0.04%	518
2024 Q4	$21.3M	Sell	512,000 -27,000	-5%	-$1.29M	0.03%	696
2024 Q3	$36M	Buy	539,000 +428,400	+387%	+$39.3M	0.05%	442
2024 Q2	$13.1M	Sell	110,600 -133,600	-55%	-$16.9M	0.02%	800
2024 Q1	$26M	Sell	244,200 -164,000	-40%	-$16.5M	0.04%	483
2023 Q4	$40.6M	Buy	408,200 +337,000	+473%	+$28.3M	0.08%	309
2023 Q3	$7.35M	Buy	+71,200	New	+$7.94M	0.02%	763

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MRNA Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Moderna (MRNA) in Q1 2026: 700,692 shares worth $35.6M. The stake represents 0.04% of the portfolio and ranks #566 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in MRNA as recently as Q4 2024.

Qube Research & Technologies (QRT) first reported a position in MRNA in Q1 2020 and has held it in 13 quarters since. The position peaked at $37.7M in Q4 2022. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Qube Research & Technologies (QRT) held 700,692 shares of Moderna worth $35.6M as of Q1 2026.
Moderna was a new Qube Research & Technologies (QRT) position in Q1 2026.
Moderna made up 0.04% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #566 holding.
Qube Research & Technologies (QRT) first reported a position in Moderna in Q1 2020 and has held it in 13 quarters since.
Qube Research & Technologies (QRT)'s Moderna position peaked at $37.7M in Q4 2022.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.